164 results for "Elliott, Perry"
Showing 1–20 · 1.00 seconds · RSS
-
Journal Article Full text
Towards a New Classification of Cardiomyopathies
PURPOSE OF REVIEW: The aim of this paper is to briefly summarise the clinical approach to disease notation for cardiomyopathies and to highlight its limitations with respect to the integration of new knowledge about aetiology. RECENT FINDINGS: The paper uses the recently advocated concept of…
-
Journal Article Full text
The genetics of hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is most commonly transmitted as an autosomal dominant trait, caused by mutations in genes encoding cardiac sarcomere proteins(1–3). Other inheritable causes of the disease include mutations in genes coding for proteins important in calcium handling or that form…
-
Journal Article Full text
Sudden death in athletes
Sudden cardiac death in an athlete is a rare and heartrending event, often occurring in the absence of warning symptoms. The causes of sudden cardiac death in athletes are age dependent and demonstrate a degree of geographical variation. Pre-participation screening is recommended by both the…
-
Journal Article Full text
The heart in Anderson‐Fabry disease and other lysosomal storage disorders
-
Journal Article Full text
Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
Arrhythmogenic cardiomyopathy (AC) is a clinical entity that has evolved conceptually over the past 30 years. Advances in cardiac imaging and the introduction of genetics into everyday practice have revealed that AC comprises multiple phenotypes that are dependent on genetic or acquired factors. In…
-
Journal Article Full text
Almanac 2011: Cardiomyopathies. the National Society Journals Present Selected Research That Has Driven Recent Advances in Clinical Cardiology
As we approach the end of 2011 it is clear that the next few years are going to be dominated by the application of new high throughput genetic screening techniques, capable of screening the entire exome or indeed genome. Understanding the data generated by these techniques will require new and…
-
Journal Article Full text
Hidden in Heart Failure
Current diagnostic strategies fail to illuminate the presence of rare disease in the heart failure population. One-third of heart failure patients are categorised as suffering an idiopathic dilated cardiomyopathy, while others are labelled only as heart failure with preserved ejection fraction…
-
Journal Article Full text
Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta‐analysis
AIMS: The study aims to systematically assess the diagnostic performance of cardiac magnetic resonance (CMR) and nuclear scintigraphy (index tests) for the diagnosis and differentiation of subtypes of cardiac amyloidosis. METHODS AND RESULTS: MEDLINE and Embase electronic databases were searched…
-
Journal Article Full text
The dilemma of an incidental preoperative electrocardiogram showing a Brugada phenotype
A Brugada pattern on routine electrocardiography is one of several features that can indicate the potential for life threatening rhythm disturbances. The authors describe such a scenario in an asymptomatic 38-year-old woman who required significant surgery under anaesthesia. The diagnosis and…
-
Journal Article Full text
Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice
Pathogenic variation in genes encoding proteins of the cardiac sarcomere is responsible for 30%–40% of cases of hypertrophic cardiomyopathy. The main clinical utility of genetic testing is to provide diagnostic confirmation and facilitation of family screening. It also assists in the detection of…
-
Journal Article Full text
Inital experience of imaging cardiac sarcoidosis using hybrid PET-MR - a technologist's case study
Also available at: PubMed Central
-
Journal Article Full text
The distribution of hypertrophy in anderson fabry disease
Also available at: PubMed Central
-
Journal Article Full text
Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis
Advances in cardiac imaging have resulted in greater recognition of cardiac amyloidosis (CA) in everyday clinical practice, but the diagnosis continues to be made in patients with late stage disease, suggesting that more needs to be done to improve awareness of its clinical manifestations and the…
-
Journal Article Full text
Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy
Mavacamten is a first-in-class, targeted, cardiac-specific myosin inhibitor approved by the US Food and Drug Administration for the treatment of adults with symptomatic New York Heart Association Classes II and III obstructive hypertrophic cardiomyopathy (oHCM). Mavacamten was developed to target…
-
Journal Article Full text
Is QT Dispersion Associated with Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy?
QT dispersion is significantly greater in patients with hypertrophic cardiomyopathy (HCM) than that in healthy subjects. Few data exist regarding the prognostic value of QT dispersion in HCM. In this study, we retrospectively investigated the association between QT dispersion and sudden cardiac…